Database : MEDLINE
Search on : Scalp and Dermatoses [Words]
References found : 3687 [refine]
Displaying: 1 .. 10   in format [Detailed]

page 1 of 369 go to page                         

  1 / 3687 MEDLINE  
              next record last record
select
to print
Photocopy

[PMID]: 29394016
[Au] Autor:Nualsri C; Lourith N; Kanlayavattanakul M
[Ti] Title:Development and clinical evaluation of green tea hair tonic for greasy scalp treatment.
[So] Source:J Cosmet Sci;67(3):161-66, 2016 May-Jun.
[Is] ISSN:1525-7886
[Cp] Country of publication:United States
[La] Language:eng
[Ab] Abstract:Green tea has cosmetic benefits that include activities against androgen disorders. A hair tonic containing green tea for reduction of scalp sebum was developed and clinically evaluated. Stable green tea hair tonics were closed-patch tested and clinically evaluated in 20 volunteers for 28 days by using a Sebumeter ® . Hair tonic base with glycerin and butylene glycol (total 4%) gained the highest consumers' preference was incorporated with green tea extract. All of the products were stable and none caused skin irritation. Green tea hair tonic (2%) significantly (p ≤ 0.024) lowered scalp sebum for 21 and 28 days following the application, suggesting that this topical therapy of scalp greasiness is safe and efficient.
[Mh] MeSH terms primary: Hair Preparations/therapeutic use
Plant Extracts/therapeutic use
Scalp Dermatoses/drug therapy
Sebum/drug effects
Tea
[Mh] MeSH terms secundary: Administration, Cutaneous
Adult
Female
Hair Preparations/pharmacology
Humans
Male
Patch Tests
Plant Extracts/pharmacology
Reference Values
Sebum/secretion
Young Adult
[Pt] Publication type:CLINICAL TRIAL; JOURNAL ARTICLE
[Nm] Name of substance:0 (Hair Preparations); 0 (Plant Extracts); 0 (Tea)
[Em] Entry month:1802
[Cu] Class update date: 180215
[Lr] Last revision date:180215
[Js] Journal subset:IM
[Da] Date of entry for processing:180203
[St] Status:MEDLINE

  2 / 3687 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy
Full text

[PMID]: 27778425
[Au] Autor:Admani S; Goldenberg A; Jacob SE
[Ad] Address:Department of Dermatology, University of California, San Diego, La Jolla, California.
[Ti] Title:Contact Alopecia: Improvement of Alopecia with Discontinuation of Fluocinolone Oil in Individuals Allergic to Balsam Fragrance.
[So] Source:Pediatr Dermatol;34(1):e57-e60, 2017 Jan.
[Is] ISSN:1525-1470
[Cp] Country of publication:United States
[La] Language:eng
[Ab] Abstract:Inflammatory scalp dermatoses can be associated with alopecia, which is nonscarring and reversible in its early stages. This association has been described in seborrheic dermatitis, psoriasis, and atopic dermatitis. We describe three girls with alopecia aggravated by contact allergy to balsam fragrances. All three had complete resolution with avoidance of balsam of Peru and other balsam derivatives (including discontinuation of fluocinolone oil, which contains balsam of pine).
[Mh] MeSH terms primary: Allergens/adverse effects
Alopecia/chemically induced
Balsams/adverse effects
Dermatitis, Allergic Contact/etiology
Perfume/adverse effects
[Mh] MeSH terms secundary: Adolescent
Alopecia/diagnosis
Child, Preschool
Dermatitis, Allergic Contact/diagnosis
Female
Humans
Patch Tests
[Pt] Publication type:CASE REPORTS
[Nm] Name of substance:0 (Allergens); 0 (Balsams); 0 (Perfume); 8P5F881OCY (Peruvian balsam)
[Em] Entry month:1704
[Cu] Class update date: 180207
[Lr] Last revision date:180207
[Js] Journal subset:IM
[Da] Date of entry for processing:161026
[St] Status:MEDLINE
[do] DOI:10.1111/pde.13011

  3 / 3687 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy
SciELO Brazil full text

[PMID]: 29186256
[Au] Autor:Bastos JT; Rocha CRMD; Silva PMCE; Freitas BMP; Cassia FF; Avelleira JCR
[Ad] Address:Department of Dermatology at Hospital Federal da Lagoa - Rio de Janeiro (RJ), Brazil.
[Ti] Title:Angiolymphoid hyperplasia with eosinophilia versus Kimura's disease: a case report and a clinical and histopathological comparison.
[So] Source:An Bras Dermatol;92(3):392-394, 2017 May-Jun.
[Is] ISSN:1806-4841
[Cp] Country of publication:Brazil
[La] Language:eng
[Ab] Abstract:Angiolymphoid hyperplasia with eosinophilia is a rare and benign vascular tumor whose etiology remains uncertain. It clinically presents itself by angiomatous papules or nodules located on the head and neck. Many controversies in the literature are found in relation to angiolymphoid hyperplasia with eosinophilia and Kimura's disease - its main differential diagnosis - due to their clinical and histopathological similarities. However, currently, most studies agree that they are distinct diseases. The present case illustrates a characteristic description of angiolymphoid hyperplasia with eosinophilia and also highlights the main differences with Kimura's disease.
[Mh] MeSH terms primary: Angiolymphoid Hyperplasia with Eosinophilia/pathology
Scalp Dermatoses/pathology
[Mh] MeSH terms secundary: Aged
Angiolymphoid Hyperplasia with Eosinophilia/diagnosis
Diagnosis, Differential
Female
Humans
Scalp Dermatoses/diagnosis
[Pt] Publication type:CASE REPORTS
[Em] Entry month:1801
[Cu] Class update date: 180131
[Lr] Last revision date:180131
[Js] Journal subset:IM
[Da] Date of entry for processing:171130
[St] Status:MEDLINE

  4 / 3687 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy
Full text

[PMID]: 28931077
[Au] Autor:Amanzougaghene N; Fenollar F; Sangaré AK; Sissoko MS; Doumbo OK; Raoult D; Mediannikov O
[Ad] Address:Aix Marseille Univ, CNRS, IRD, INSERM, AP-HM, URMITE, IHU - Méditerranée Infection, Marseille, France.
[Ti] Title:Detection of bacterial pathogens including potential new species in human head lice from Mali.
[So] Source:PLoS One;12(9):e0184621, 2017.
[Is] ISSN:1932-6203
[Cp] Country of publication:United States
[La] Language:eng
[Ab] Abstract:In poor African countries, where no medical and biological facilities are available, the identification of potential emerging pathogens of concern at an early stage is challenging. Head lice, Pediculus humanus capitis, have a short life, feed only on human blood and do not transmit pathogens to their progeny. They are, therefore, a perfect tool for the xenodiagnosis of current or recent human infection. This study assessed the occurrence of bacterial pathogens from head lice collected in two rural villages from Mali, where a high frequency of head lice infestation had previously been reported, using molecular methods. Results show that all 600 head lice, collected from 117 individuals, belonged to clade E, specific to West Africa. Bartonella quintana, the causative agent of trench fever, was identified in three of the 600 (0.5%) head lice studied. Our study also shows, for the first time, the presence of the DNA of two pathogenic bacteria, namely Coxiella burnetii (5.1%) and Rickettsia aeschlimannii (0.6%), detected in human head lice, as well as the DNA of potential new species from the Anaplasma and Ehrlichia genera of unknown pathogenicity. The finding of several Malian head lice infected with B. quintana, C. burnetii, R. aeschlimannii, Anaplasma and Ehrlichia is alarming and highlights the need for active survey programs to define the public health consequences of the detection of these emerging bacterial pathogens in human head lice.
[Mh] MeSH terms primary: Bartonella quintana/genetics
DNA, Bacterial/genetics
Insect Vectors/microbiology
Lice Infestations/diagnosis
Pediculus/microbiology
Scalp Dermatoses/diagnosis
Trench Fever/transmission
[Mh] MeSH terms secundary: Animals
Bartonella quintana/classification
Bartonella quintana/isolation & purification
DNA, Bacterial/classification
DNA, Bacterial/isolation & purification
Humans
Lice Infestations/microbiology
Mali
Phylogeny
Polymerase Chain Reaction
Scalp Dermatoses/microbiology
Trench Fever/microbiology
[Pt] Publication type:JOURNAL ARTICLE
[Nm] Name of substance:0 (DNA, Bacterial)
[Em] Entry month:1710
[Cu] Class update date: 171017
[Lr] Last revision date:171017
[Js] Journal subset:IM
[Da] Date of entry for processing:170921
[St] Status:MEDLINE
[do] DOI:10.1371/journal.pone.0184621

  5 / 3687 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy
Full text

[PMID]: 28883737
[Au] Autor:Cohen PR
[Ad] Address:Department of Dermatology, University of California San Diego, La Jolla, CA, USA.
[Ti] Title:Scabies masquerading as bullous pemphigoid: scabies surrepticius.
[So] Source:Clin Cosmet Investig Dermatol;10:317-324, 2017.
[Is] ISSN:1178-7015
[Cp] Country of publication:New Zealand
[La] Language:eng
[Ab] Abstract:Scabies, a parasitic infestation caused by the mite , is diagnosed by observing either the mite, its ova, or its excrement. The mite tracts, known as burrows and a characteristic presentation of the pruritic condition, are typically found on the web spaces between the fingers. Other cutaneous lesions include excoriated papules, pustules, and vesicles. However, atypical clinical variants of scabies, such as bullous, crusted, hidden, incognito, nodular, and scalp forms of the parasitic infestation, mimic the morphologic features of other non-parasitic dermatoses. A 76-year-old man presented with pruritic blisters and urticarial plaques that demonstrated not only pathology changes, but direct immunofluorescence also showed findings of bullous pemphigoid. His condition improved, but did not resolve, with topical corticosteroid cream for the management of the primary autoimmune blistering disorder. When other family members subsequently developed scabies, the correct diagnosis for his condition, bullous scabies, was established by demonstrating mites, ova, and scybala on a mineral oil preparation from a skin scraping of a newly appearing burrow. Bullous scabies can masquerade not only clinically, but also both pathologically and immunologically as bullous pemphigoid. Scabies serrupticius is introduced as a unifying term to designate all of the non-classic presentations of mite infestation.
[Pt] Publication type:JOURNAL ARTICLE
[Em] Entry month:1709
[Cu] Class update date: 170910
[Lr] Last revision date:170910
[St] Status:PubMed-not-MEDLINE
[do] DOI:10.2147/CCID.S145494

  6 / 3687 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy
Full text

[PMID]: 28813557
[Au] Autor:Mervak JE; Gan SD; Smith EH; Wang F
[Ad] Address:Department of Dermatology, University of Michigan Medical School, Ann Arbor.
[Ti] Title:Facial Erosive Pustular Dermatosis After Cosmetic Resurfacing.
[So] Source:JAMA Dermatol;153(10):1021-1025, 2017 Oct 01.
[Is] ISSN:2168-6084
[Cp] Country of publication:United States
[La] Language:eng
[Ab] Abstract:Importance: Erosive pustular dermatosis (EPD) is a rare condition that typically affects actinically damaged skin of the scalp. Characterized by sterile pustules, erosions, and crusts, EPD is difficult to treat and heals slowly. The exact cause of EPD is unknown, although trauma is an inciting factor. Objective: To describe 3 women who presented with prolonged facial erosions after cosmetic resurfacing procedures, specifically fully ablative carbon dioxide laser or medium-depth chemical peel. Design, Setting, and Participants: This case series describes the clinical features, histopathological findings, laboratory results, and treatment of 3 patients with an ultimate diagnosis most consistent with facial EPD. Patients were evaluated between September 10, 2010, and May 6, 2016, in a dermatology clinic in an academic medical center. The patients were 3 women seeking diagnostic evaluation and therapeutic options for nonhealing facial erosions occurring after ablative procedures (carbon dioxide laser resurfacing or Jessner solution/trichloroacetic acid chemical peel). Main Outcomes and Measures: Histologic examination and wound culture from initial presentation as well as clinical follow-up documenting improvement with therapeutic interventions. Results: All 3 patients were women in their 50s or 60s for whom EPD was deemed to be the best diagnosis, after infection, immunobullous disorders, and other pustular dermatoses were considered. Histologic features were nonspecific. Treatment included a combination of topical and systemic therapies, such as corticosteroids, dapsone, isotretinoin, and/or antibiotics. Watchful waiting (tincture of time) appeared to be central to the healing process. Conclusions and Relevance: After cosmetic resurfacing, patients may develop EPD isolated to the face. As a diagnosis of exclusion that should be considered in patients who have nonhealing wounds following ablative procedures, EPD is challenging to treat and may require the use of anti-inflammatory agents. Recognizing this condition is important, especially as cosmetic procedures become more widespread.
[Mh] MeSH terms primary: Chemexfoliation/methods
Facial Dermatoses/therapy
Lasers, Gas/therapeutic use
Skin Diseases, Vesiculobullous/therapy
[Mh] MeSH terms secundary: Combined Modality Therapy
Facial Dermatoses/pathology
Female
Humans
Middle Aged
Skin Diseases, Vesiculobullous/pathology
Treatment Outcome
[Pt] Publication type:CASE REPORTS; JOURNAL ARTICLE
[Em] Entry month:1710
[Cu] Class update date: 171023
[Lr] Last revision date:171023
[Js] Journal subset:AIM; IM
[Da] Date of entry for processing:170817
[St] Status:MEDLINE
[do] DOI:10.1001/jamadermatol.2017.2880

  7 / 3687 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy
Full text

[PMID]: 28785321
[Au] Autor:Wollina U; Langner D; Hansel G; Koch A; Tchernev G
[Ad] Address:Department of Dermatology and Allergology, Academic Teaching Hospital Dresden-Friedrichstadt, Friedrichstrasse 41, 01067, Dresden, Germany.
[Ti] Title:Scalping Surgery - Dermatologic Indications beyond Curative Primary Skin Cancer Surgery.
[So] Source:Open Access Maced J Med Sci;5(4):414-419, 2017 Jul 25.
[Is] ISSN:1857-9655
[Cp] Country of publication:Macedonia
[La] Language:eng
[Ab] Abstract:Skin tumours are among the most frequent tumour types of mankind. In the case of large tumours, field cancerization, or satellitosis scalping surgery is a possible option. The procedure can also be used in a palliative setting with tumour debulking. Less common indications are multiple benign tumours of the scalp and chronic inflammatory scalp dermatoses not responding to medical treatment. We present a case series and discuss surgical modalities beyond curative surgery of primary skin cancer.
[Pt] Publication type:JOURNAL ARTICLE
[Em] Entry month:1708
[Cu] Class update date: 170810
[Lr] Last revision date:170810
[St] Status:PubMed-not-MEDLINE
[do] DOI:10.3889/oamjms.2017.115

  8 / 3687 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy
Full text

[PMID]: 28780364
[Au] Autor:Bagel J; Duffin KC; Moore A; Ferris LK; Siu K; Steadman J; Kianifard F; Nyirady J; Lebwohl M
[Ad] Address:Psoriasis Treatment Center of Central New Jersey, East Windsor, New Jersey. Electronic address: dreamacres1@aol.com.
[Ti] Title:The effect of secukinumab on moderate-to-severe scalp psoriasis: Results of a 24-week, randomized, double-blind, placebo-controlled phase 3b study.
[So] Source:J Am Acad Dermatol;77(4):667-674, 2017 Oct.
[Is] ISSN:1097-6787
[Cp] Country of publication:United States
[La] Language:eng
[Ab] Abstract:BACKGROUND: Moderate-to-severe scalp psoriasis has not been evaluated in prospective trials of patients without moderate-to-severe body psoriasis. OBJECTIVE: Evaluate the efficacy and safety of secukinumab in moderate-to-severe scalp psoriasis. METHODS: In this 24-week, double-blind, phase 3b study, 102 patients were randomized 1:1 to subcutaneous secukinumab 300 mg or placebo at baseline, weeks 1, 2, and 3, and then every 4 weeks from week 4 to 20. The primary efficacy variable was 90% improvement of Psoriasis Scalp Severity Index (PSSI 90) score from baseline to week 12. RESULTS: At week 12, PSSI 90 (secukinumab 300 mg vs placebo, 52.9% vs 2.0%) and Investigator's Global Assessment modified 2011 scalp responses of 0 or 1 (secukinumab 300 mg vs placebo, 56.9% vs 5.9%) were significantly greater with secukinumab 300 mg than placebo (P < .001 for both). In addition, significantly more patients achieved complete clearance of scalp psoriasis at week 12 with secukinumab 300 mg than placebo (35.3% vs 0%; P < .001). The median time to 50% reduction in PSSI score was 3.29 weeks with secukinumab 300 mg. The safety profile of secukinumab was consistent with previous phase 3 studies. LIMITATIONS: There was no active comparator arm. CONCLUSION: Secukinumab is efficacious and well-tolerated for patients with extensive moderate-to-severe scalp psoriasis.
[Mh] MeSH terms primary: Antibodies, Monoclonal/therapeutic use
Dermatologic Agents/therapeutic use
Psoriasis/drug therapy
Scalp Dermatoses/drug therapy
[Mh] MeSH terms secundary: Adult
Antibodies, Monoclonal/adverse effects
Dermatologic Agents/adverse effects
Double-Blind Method
Female
Humans
Male
Middle Aged
Severity of Illness Index
Time Factors
Treatment Outcome
[Pt] Publication type:CLINICAL TRIAL, PHASE III; JOURNAL ARTICLE; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL
[Nm] Name of substance:0 (Antibodies, Monoclonal); 0 (Dermatologic Agents); DLG4EML025 (secukinumab)
[Em] Entry month:1709
[Cu] Class update date: 170927
[Lr] Last revision date:170927
[Js] Journal subset:IM
[Da] Date of entry for processing:170807
[St] Status:MEDLINE

  9 / 3687 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy
Full text

[PMID]: 28679382
[Au] Autor:Zaid AN; Jaradat NA; Eid AM; Al Zabadi H; Alkaiyat A; Darwish SA
[Ad] Address:Department of Pharmacy, Faculty of Medicine and Health Sciences, An-Najah National University, P.O. Box 7, Nablus, Palestine. anzaid@najah.edu.
[Ti] Title:Ethnopharmacological survey of home remedies used for treatment of hair and scalp and their methods of preparation in the West Bank-Palestine.
[So] Source:BMC Complement Altern Med;17(1):355, 2017 Jul 05.
[Is] ISSN:1472-6882
[Cp] Country of publication:England
[La] Language:eng
[Ab] Abstract:BACKGROUND: Natural products have many uses and purposes, including those linked to pharmaceutics and cosmetics. The aim of this study was to investigate the use of natural remedies for the treatment of hair and scalp disorders in the West Bank, Palestine. METHODS: An ethnopharmacological survey of herbal remedies and other natural products used in cosmetics and cosmeceuticals was carried out in the West Bank, Palestine. A questionnaire was distributed to 267 herbalists, traditional healers, hairdressers and rural dwellers. Collected information included: the names of plants and other natural products, the parts used, hair conditions, diseases and problems for which these products were used and also their methods of preparation. To identify the most important species used, the factor of informant's consensus (F ), fidelity level (Fl) and the use-value (UV) were calculated. RESULTS: Collected data showed that 41 plants are utilized for the treatment of hair and scalp disorders, belonging to 27 families; among them Lamiaceae and Rosaceae, which were the most commonly used. Plant oils and their fruits are the most commonly used parts. Hair loss, dandruff, split hair endings and lice treatment, are reported as the most treated disorders. The number of plant species used consisted of 19, 14, 13, and again 13 with a factor of informant's consensus (Fic) for these disorders corresponding to 0.93, 0.94, 0.95 and 0.92, respectively. Fl was 100% for many plants; the highest UV value (0.84) was registered for Lawsonia inermis, which belongs to the Lythraceae family. CONCLUSIONS: This study showed that many natural remedies are still used in Palestine for the treatment of scalp and hair disorders as well as for cosmeceutical purposes. This study is of great importance as it allows us to have a greater perspective on our folkloric use of these natural products. A combined scientific effort between informants and the scientific community, working in this field, may help in the discovery of new cosmetics, cosmeceutical and nutraceutical products.
[Mh] MeSH terms primary: Ethnopharmacology
Hair Diseases/drug therapy
Medicine, Traditional/utilization
Plant Preparations/therapeutic use
Scalp Dermatoses/drug therapy
[Mh] MeSH terms secundary: Adolescent
Adult
Drug Compounding
Female
Hair/drug effects
Hair Diseases/ethnology
Humans
Male
Middle Aged
Middle East/ethnology
Plant Preparations/chemistry
Scalp Dermatoses/ethnology
Young Adult
[Pt] Publication type:JOURNAL ARTICLE
[Nm] Name of substance:0 (Plant Preparations)
[Em] Entry month:1708
[Cu] Class update date: 170824
[Lr] Last revision date:170824
[Js] Journal subset:IM
[Da] Date of entry for processing:170707
[St] Status:MEDLINE
[do] DOI:10.1186/s12906-017-1858-1

  10 / 3687 MEDLINE  
              first record previous record
select
to print
Photocopy
Full text

[PMID]: 28624120
[Au] Autor:Chung HJ; Goldberg LJ
[Ad] Address:Section of Dermatopathology, Department of Dermatology, Boston University School of Medicine, Boston, Massachusetts.
[Ti] Title:Histologic features of chronic cutaneous lupus erythematosus of the scalp using horizontal sectioning: Emphasis on follicular findings.
[So] Source:J Am Acad Dermatol;77(2):349-355, 2017 Aug.
[Is] ISSN:1097-6787
[Cp] Country of publication:United States
[La] Language:eng
[Ab] Abstract:BACKGROUND: Chronic cutaneous lupus erythematosus (CCLE) often affects the scalp resulting in scarring alopecia. While histopathologic findings of CCLE have been well described, there is little written on the morphologic changes to the hair follicles in this condition. OBJECTIVE: We aim to determine the histopathologic findings of hair follicles in CCLE of the scalp. METHODS: We conducted a retrospective study of 33 transversely sectioned skin biopsy specimens of CCLE of the scalp at the Skin Pathology Laboratory at Boston University between April 2005 and March 2015. RESULTS: New findings include basaloid follicular epithelium lacking hair follicles at deep levels, follicular miniaturization, increased catagen/telogen hair follicles, and pigment casts. Two histopathologic patterns could be discerned, an alopecia areatalike pattern and a lichen planopilarislike pattern. LIMITATIONS: Generalizability of a single-center experience may be limited. CONCLUSION: Follicular findings in CCLE of the scalp are reported. We hypothesize that the basaloid aggregates are remnants of hair follicles that are no longer actively cycling.
[Mh] MeSH terms primary: Hair Follicle/pathology
Lupus Erythematosus, Discoid/pathology
Scalp Dermatoses/pathology
[Mh] MeSH terms secundary: Adult
Aged
Aged, 80 and over
Chronic Disease
Female
Histocytological Preparation Techniques/methods
Humans
Male
Middle Aged
Retrospective Studies
Young Adult
[Pt] Publication type:JOURNAL ARTICLE
[Em] Entry month:1708
[Cu] Class update date: 170825
[Lr] Last revision date:170825
[Js] Journal subset:IM
[Da] Date of entry for processing:170619
[St] Status:MEDLINE


page 1 of 369 go to page                         
   


Refine the search
  Database : MEDLINE Advanced form   

    Search in field  
1  
2
3
 
           



Search engine: iAH v2.6 powered by WWWISIS

BIREME/PAHO/WHO - Latin American and Caribbean Center on Health Sciences Information